Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 70, Issue 2, 2008, Pages 493-499

  Konno, Hajime ^a   Handa, Tetsurou ^b   Alonzo, David E ^c   Taylor, Lynne S ^c  

^a ASTELLAS PHARMA INC   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c PURDUE UNIVERSITY   (United States)

Author keywords

Amorphous; Concentration; Dissolution; Solid dispersion

Indexed keywords

AQOAT; FELODIPINE; HYDROXYPROPYLMETHYLCELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE ACETATE SUCCINATE; PHARMACOAT; POLYMER; POVIDONE IODINE; UNCLASSIFIED DRUG;

ARTICLE; CRYSTALLIZATION; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STABILITY; SOLID;

CRYSTALLIZATION; FELODIPINE; METHYLCELLULOSE; POLYMERS; POLYVINYLS; PYRROLIDINES; SOLUBILITY; THERMODYNAMICS;

EID: 52949150391     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2008.05.023     Document Type: Article

References (34)

1. Choiu W.L., and Riegelman S. Oral absorption of griseofulvin in dogs: increased absorption via solid dispersion in polyethylene glycol 6000. J. Pharm. Sci. 59 (1970) 937-942
2. Goldberg A.H., Gibaldi M., and Kanig J.L. Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions. J. Pharm. Sci. 55 (1966) 487-492
3. Hancock B.C., and Parks M. What is the true solubility advantage for amorphous pharmaceuticals?. Pharm. Res. 17 (2000) 397-404
4. Six K., Verreck G., Peeters J., Brewster M., and Van den Mooter G. Increased physical stability and improved dissolution properties of itraconazole, a class II drug, by solid dispersions that combine fast- and slow-dissolving polymers. J. Pharm. Sci. 93 (2004) 124-131
5. Leuner C., and Dressman J. Improving drug solubility for oral delivery using solid dispersion. Eur. J. Pharm. Biopharm. 50 (2000) 47-60
6. Chiou W.L., and Riegelman S. Pharmaceutical applications of solid dispersions. J. Pharm. Sci. 60 (1971) 1281-1302
7. Serajuddin A.T.M. Solid dispersions of poorly water-soluble drugs: early promises, subsequent problems and recent breakthroughs. J. Pharm. Sci. 88 (1999) 1058-1066
8. Jolley J.E. Microstructure of photographic gelatin binders. Photogr. Sci. Eng. 14 (1970) 169-177
9. Van den Mooter G., Wuyts M., Blaton N., Busson R., Augustijns P.GrobetP., and Kinge R. Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25. Eur. J. Pharm. Sci. 12 3 (2001) 261-269
10. Oksanen C.A., and Zografi G. The relationship between the glass transition temperature and water vapor absorption by poly(vinylpyrrolidone). Pharm. Res. 7 (1990) 654-657
11. Aso Y., Yoshioka S., Chang J., and Zografi G. Effect of water on the molecular mobility of sucrose and poly(vinylpyrrolidone) in a colyophilized formulation as measured by C-13 NMR relaxation time. Chem. Pharm. Bull. 50 6 (2002) 822-826
12. Taylor L.S., and Zografi G. Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm. Res. 14 (1997) 1691-1698
13. Miyazaki T., Yoshioka S., Aso Y., and Kojima S. Ability of polyvinylpyrrolidone and polyacrylic acid to inhibit the crystallization of amorphous acetaminophen. J. Pham. Sci. 93 (2004) 2710-2717
14. Aso Y., and Yohioka S. Molecular mobility of nifedipine-PVP and phenobarbital-PVP solid dispersions as measured by 13C NMR spin-lattice relaxation time. J. Pharm. Sci. 95 (2006) 318-325
15. Marsac P.J., Konno H., and Taylor L.S. A comparison of the physical stability of amorphous felodipine and nifedipine systems. Pharm. Res. 10 (2006) 2306-2316
16. Gupta P., Kakumanu V.K., and Bansal A.K. Stability and solubility of Celecoxib-PVP amorphous dispersions: a molecular perspective. Pharm. Res. 21 (2004) 1762-1769
17. Tanno F., Nishiyama Y., Kokubo H., and Obara S. Evaluation of hypromellose acetate succinate (HPMCAS) as a carrier in solid dispersions. Drug. Dev. Ind. Pharm. 30 (2004) 9-17
18. Usui F., Maeda K., Kusai A., Nishimura K., and Yamamoto K. Inhibitory effects of water-soluble polymers on precipitation of RS-8359. Int. J. Pharm. 154 (1997) 59-66
19. Acartürk F., Kislal O., and Celebi N. The effect of some natural polymers on the solubility and dissolution characteristic of nifedipine. Int. J. Pharm. 85 (1992) 1-6
20. Loftsson T., Fridriksdóttir F., and Gudmundsdóttir T.K. The effect of water-soluble polymers on aqueous solubility of drugs. Int. J. Pharm. 127 (1996) 293-296
21. Konno H., and Taylor L.S. Stabilizing ability of different polymers on the crystallization of molecularly dispersed amorphous felodipine. J. Pharm. Sci. 95 (2006) 2692-2705
22. Konno H., and Taylor L.S. Ability of different polymers to inhibit the crystallization of amorphous felodipine in the presence of moisture. Pharm. Res. 25 (2008) 969-978
23. Bynum K., Roinestad K., Kassis A., Pocreva J., Gehrlein L., Cheng F., and Palermo J. Analytical performance of a fiber optic probe dissolution system. Dissol. Technol. 8 4 (2001) 13-21
24. Von Corswant C., Thorén P., and Engström S. Triglyceride-based microemulsion for intravenous administration sparingly soluble substances. J. Pharm. Sci. 87 (1998) 200-208
25. Hancock B.C., and Zografi G. Characteristics and significance of the amorphous state in pharmaceutical systems. J. Pharm. Sci. 86 (1997) 1-12
26. Parks G.S., Huffman H.M., and Cattor F.R. Studies on glass. II: the transition between the glassy and liquid states in the case of glucose. J. Phys. Chem. 32 (1928) 1366-1379
27. Parks G.S., Snyder L.J., and Cattoir F.R. Studies on glass. XI: some thermodynamic relations of glassy and alpha-crystalline glucose. J. Chem. Phys. 2 (1934) 595-598
28. Turnbull D., and Fischer J.C. Rate of nucleation in condensed systems. J. Chem. Phys. 17 (1949) 71-73
29. Simonelli A.P., Metha S.C., and Higuchi W.I. Dissolution rates of high energy sulfathiazide-povidone coprecipitates II: characterization of form of drug controlling its dissolution rate via solubility studies. J. Pharm. Sci. 65 (1976) 355-360
30. Matsumoto T., and Zografi G. Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization. Pharm. Res. 16 (1999) 1722-1728
31. Hasegawa A., Taguchi M., Suzuki R., Miyata T., Nakagawa H., and Sugimoto I. Supersaturation mechanism of drugs from solid dispersions with enteric coating agents. Chem. Pharm. Bull. 36 (1988) 4941-4950
32. Suzuki H., and Sunada H. Influence of water-soluble polymers on the dissolution of nifedipine solid dispersions with combined carriers. Chem. Pharm. Bull. 46 (1998) 482-487
33. Hasegawa A., Kawamura R., Nakagawa H., and Sugimoto I. Dissolution mechanism of solid dispersions of nifedipine with enteric coating agents. J. Pharm. Sci. Technol. Jpn. 106 (1985) 586-592
34. J. Garside, A. Mersmann, J. Nyvlt, Measurement of crystal growth and nucleation, IChemE, second Ed., 2002, p. 15.